CYP19A1 and breast cancer: This study identified a new potential AI-treatment predictive marker in CYP1A2 rs762551 for early breast cancer events, and the results indicate that CYP1A2 rs762551 in combination with CYP19A1 rs4646 or AhR Arg554Lys may yield even better treatment prediction.